Investigational Site Number :1560014

Shenyang 110004

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Multiple Sclerosis

Studies at this site

• Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis — Running, not enrolling
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation — Completed